Mental health, addiction, and pain treatment will be fundamentally transformed by psychedelic drugs over the coming decade, giving rise to a multi-billion-dollar industry with the potential to drastically improve patient outcomes across a range of indications. Investors are starting to take notice and major backers are getting involved.